Other
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Over 3 years (FY 2020 to FY 2025), Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax shows a downward trend with a -100.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
An increase signals a decline in the market value of the investment portfolio, often due to rising interest rates or credit spread widening.
Detailed definition
The total amount of unrealized losses on debt securities classified as available-for-sale, measured before the impact of...
Peer comparison
Standard metric for insurance companies and banks with significant fixed-income holdings.
Metric ID:
other_available_for_sale_debt_securities_accumulated_gro_6005e2Historical Data
12 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.10M | $1.00M | $3.20M | $16.40M | $25.80M | $27.00M | $20.20M | $14.90M | $19.40M | $0.00 | $0.00 | $2.00M |
| QoQ Change | — | -9.1% | +220.0% | +412.5% | +57.3% | +4.7% | -25.2% | -26.2% | +30.2% | -100.0% | — | — |
| YoY Change | — | — | — | — | >999% | >999% | +531.3% | -9.1% | -24.8% | — | — | — |
Range$0.00 – $27.00M
CAGR+24.3%
Avg YoY Growth>999%
Median YoY Growth+531.3%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax at Other Companies
Frequently Asked Questions
- What is Biogen's debt securities, available-for-sale, accumulated gross unrealized loss, before tax?
- Biogen (BIIB) reported debt securities, available-for-sale, accumulated gross unrealized loss, before tax of $2.00M in Q1 2026.
- What is the long-term trend for Biogen's debt securities, available-for-sale, accumulated gross unrealized loss, before tax?
- Over 3 years (2020 to 2025), Biogen's debt securities, available-for-sale, accumulated gross unrealized loss, before tax has grown at a -100.0% compound annual growth rate (CAGR), from $400.00K to $0.00.
- What does debt securities, available-for-sale, accumulated gross unrealized loss, before tax mean?
- The total paper loss on debt investments that have not been sold yet, before tax adjustments.